Transcription

2 Alison Sahoo Alison Sahoo is a pharmaceutical industry analyst with more than 10 years of experience researching the development of medicines and medical devices. She holds a B.S. in Physics from McGill University and an MBA in International Business from Rutgers University. Copyright 2010 Business Insights Ltd This Management Report is published by Business Insights Ltd. All rights reserved. Reproduction or redistribution of this Management Report in any form for any purpose is expressly prohibited without the prior consent of Business Insights Ltd. The views expressed in this Management Report are those of the publisher, not of Business Insights. Business Insights Ltd accepts no liability for the accuracy or completeness of the information, advice or comment contained in this Management Report nor for any actions taken in reliance thereon. While information, advice or comment is believed to be correct at the time of publication, no responsibility can be accepted by Business Insights Ltd for its completeness or accuracy. ii

Key Findings The global CRO industry valued $18bn in 2008, an increase of 14% over 2007. The CRO market will grow at an annual rate of 14% over the 2009 13 period. Quintiles leads the global CRO market

An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore A CanBiotech Report CanBiotech, 2007 1 An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight

Pharmaceutical business innovation through utilization of EMR Abstract The pharmaceutical industry in Japan is in a transformation phase due to the government s tightening control over healthcare expenditure

The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE THIS POLICY OUTLINES THE TOP LEVEL REQUIREMENTS TO SUPPORT PRODUCT QUALITY IN THE DEVELOPMENT, MANUFACTURE AND DISTRIBUTION OF ACTIVE PHARMACEUTICAL

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical

1 Disclaimer The research reports provided by AM Mindpower Solutions are for the personal information of the authorised recipient and is not for public distribution and should not be reproduced or redistributed

Pharmaxis Ltd 1. Board responsibility The Pharmaxis Board is responsible for ensuring the Company establishes and maintains a risk management framework for the oversight and management of risk. The Board

The Procurement Value IN LIFE SCIENCE and the key challenges to efficient execution Table of Contents Executive summary 3 1 Procurement: Untapped value for Pharmaceutical companies 4 2 Three main challenges

Workers Compensation Overview November 2013 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which

1 Industry Perspective Over the last several years, clinical research costs have sky rocketed while new drug approvals are at multi-year lows. Studies have become global in nature and more complex to manage

Public Policy Statement: Clinical Trial Ethics Purpose As a global healthcare company, Merck's role is first and foremost to discover, develop and provide innovative products and services that save and

Clinical Trials in Key Challenges Executive Summary KPMG in kpmg.com/bg Global determinants of the sector The Report explores a selection of factors which according to the performed analysis have substantial

Medical Information and Pharmacovigilance through acquisition Lisa Hughes Medical Affairs Manager Actavis UK Ltd Disclaimer The views and opinions expressed in the following presentation are those of the

What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? for 2015 DIA has released its third annual What Lies Ahead? report, providing experts insights into the

Offshore Insights White Paper www.neoit.com November 2003 Issue 14 RESEARCH SUMMARY: Challenges with Offshore Business Process Outsourcing By neoit More than half of the world's top 500 companies outsource

04/15/15 FINAL DATA SHARING AGREEMENT This DATA SHARING AGREEMENT (this Agreement ) is effective as of, (the Effective Date ) between (the Institution ), located at and ( Study Sponsor ) located at, regarding

Can India be the Leader in Global Generics Rtn. J. Jayaseelan.,B.Pharm., M.B.A., Managing Director Indian Pharma Industry Before 1970 Depending on MNC from USA and Europe for supply of Medicines Hardly

HEALTHCARE STAFFING MARKET OVERVIEW November 2015 HEALTHCARE STAFFING INDUSTRY OVERVIEW Healthcare staffing is an $11.1 billion industry in the United States, with expected growth of 7% per annum through

Coming together is a beginning, keeping together is progress, working together is success. - Henry Ford - Considering the clinical research industry as an area for enhanced public-private sector collaboration

Bridge to Europe Seuss Consulting makes your EU plans come together. Pharmaceutical and biotech sponsors & suppliers know that at some point they need to expand operations into Europe to service existing

1 P age TERM SHEET EXAMPLE BIOTECHCO Overview & Business Strategy BIOTECHCO (the licensor), located in North Dakota, has a proprietary technology called ZIP that can generate fully human antibodies with

Commercial Insight: Cytotoxic Therapies Market Growth Will Slow Due To Increasing Genericization Report summary In-depth analysis of the current and future cytotoxic therapies market across the US, 5EU

340B DISCOUNT DRUG PROGRAM OVERVIEW March 2014 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which

Drug Development Models in China and the Impact on Multinational Pharmaceutical Companies By Ling Su, Ph.D. China represents a huge potential opportunity for the pharmaceutical industry in both commercial

IPROVE Innovation Partnership for a Roadmapon VaccinesinEurope IPROVE IN BRIEF What is IPROVE? Whydo we need IPROVE? IPROVE in actions (How?) Partnership (Who?) WHAT An EU project (FP7) financed by the

CLINICAL TRIALS IN AUSTRALIA: SUN, BEACHES AND LIFESTYLE ARE NOT THE ONLY REASONS TO GO THERE Although the major drug development regions of the world are recognized to be North America, Europe and Japan,

Finding a cure for pharma. How is risk aversion holding the industry back? 2 Finding a cure for pharma. The pharmaceutical industry is facing significant challenges. From discovery to commercial realisation,

Visit http://store.centerwatch.com to learn more about State of the Clinical Trials Industry 2008 Special Article Reprint For the latest news and views on the clinical trials industry visit ClinicalTrialsToday.com

ARTICLE AUGUST 2014 Anti-counterfeiting Technology Author Sarabjeet Singh Sharad F Abstract: International free trade and inadequate drug regulation have led to the expansion of trade in counterfeit drugs

Drug Pooling in Clinical Trial Supply Chain Drug pooling in clinical trial is a process where common IMPs or Non-IMPs are pooled together for similar protocols running at each site followed by pooled distribution

Even we will get to use your product someday. Enough reason for us to deliver. ClinInvent: Putting our heart and soul behind the research. At ClinInvent, when we talk about clinical research it s not just

R&D for Development of New Drugs for Neglected Diseases: A Proposal for South South Cooperation Sudip Chaudhuri Indian Institute of Management Calcutta DNDi Intellectual Property Workshop New Delhi 4 December,

1 technavio insights About TechNavio Technavio is the research platform of Infiniti Research. Infiniti Research provides actionable market intelligence to leading companies worldwide. A team of 120 analysts